Beta Bionics, Inc. (BBNX) financial statements and ratios from SEC XBRL: revenue $100.25M (TTM), net margin -73.0%, revenue growth 37.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $100.25M |
| Net Margin | -73.0% |
| Revenue Growth (YoY) | 37.8% |
| EPS Growth (YoY) | 35.9% |
| FCF Growth (YoY) | 1.9% |
| Price / Book | 3.42 |
| Price / Sales | 7.37 |
| FCF Yield | -7.0% |
| Altman Z-Score | 11.49 (safe) |
| Sector P/E (Healthcare) | 21.6 |
BBNX overview · BBNX earnings · BBNX KPIs · BBNX investor relations · BBNX ownership · BBNX peers · BBNX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.